Hemodynamic effects of orally administered Sunitang in humans. 1987

H C Chen, and M T Hsieh

The hemodynamic effects of Sunitang, an ancient Chinese remedy for general weakness, weak pulse, and cold extremities, were studied. In study, 1, 10 patients with left ventricular failure received Sunitang in single oral doses of 250, 500, and 1000 mg in a double-blind manner. Sunitang showed dose-related positive inotropic, chronotropic, and vasodilator effects. The effects reached their maximum within 30 to 60 minutes and lasted for 6 hours. In study 2, 77 patients with left ventricular failure who had not been treated satisfactorily by the conventional methods entered a controlled (parallel design), double-blind study for 1 month. When they entered the study they were in steady states. They continued their original medications throughout the month. Sunitang showed additional positive inotropic, chronotropic, and vasodilator effects. In this study no apparent adverse effects of Sunitang were noted. We conclude from these results that Sunitang may be useful in heart failure and bradycardia.

UI MeSH Term Description Entries
D008518 Medicine, East Asian Traditional Medical practice or discipline that is based on the knowledge, cultures, and beliefs of the people in EAST ASIA. Traditional Medicine, East Asia,East Asian Medicine,East Asian Traditional Medicine,Medicine, East Asia,Medicine, Far East,Medicine, Oriental,Medicine, Oriental Traditional,Medicine, Traditional, East Asia,Oriental Medicine,Oriental Medicine, Traditional,Oriental Traditional Medicine,Traditional East Asian Medicine,Traditional Far Eastern Medicine,Traditional Medicine, Oriental,Asia Medicines, East,East Asia Medicine,East Asia Medicines,East Asian Medicines,East Medicine, Far,East Medicines, Far,Far East Medicine,Far East Medicines,Medicine, East Asian,Medicine, Traditional Oriental,Medicines, East Asia,Medicines, Far East,Traditional Oriental Medicine,Traditional Oriental Medicines
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002316 Cardiotonic Agents Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). Cardiac Stimulant,Cardiac Stimulants,Cardioprotective Agent,Cardioprotective Agents,Cardiotonic,Cardiotonic Agent,Cardiotonic Drug,Inotropic Agents, Positive Cardiac,Myocardial Stimulant,Myocardial Stimulants,Cardiotonic Drugs,Cardiotonics,Agent, Cardioprotective,Agent, Cardiotonic,Drug, Cardiotonic,Stimulant, Cardiac,Stimulant, Myocardial
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013268 Stimulation, Chemical The increase in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Stimulation,Chemical Stimulations,Stimulations, Chemical

Related Publications

H C Chen, and M T Hsieh
April 2005, American journal of veterinary research,
H C Chen, and M T Hsieh
April 2013, World journal of urology,
H C Chen, and M T Hsieh
January 1986, Journal of pharmaceutical sciences,
H C Chen, and M T Hsieh
February 1979, The American journal of cardiology,
H C Chen, and M T Hsieh
January 1986, Journal of cardiovascular pharmacology,
H C Chen, and M T Hsieh
December 1987, Journal of pharmaceutical sciences,
H C Chen, and M T Hsieh
March 1981, Journal of pharmaceutical sciences,
H C Chen, and M T Hsieh
May 1981, Journal of pharmaceutical sciences,
H C Chen, and M T Hsieh
January 1994, International ophthalmology,
Copied contents to your clipboard!